HOBOKEN, N.J.--October 2, 2019-- John Wiley and Sons Inc. (NYSE: JW-A) (NYSE: JW-B) and the Alzheimer's Association® are pleased to announce that the Alzheimer's Association has selected Wiley as its publishing partner for its three publications Alzheimer's & Dementia®:The Journal of the Alzheimer's Association (A&D), Alzheimer's & Dementia®:Diagnosis, Assessment & Disease Monitoring (DADM), and Alzheimer's & Dementia®:Translational Research & Clinical Interventions (TRCI). The journals will transition to the Wiley Online Library platform following the publication of the November/December 2019 issue.
"The Alzheimer's Association looks forward to our partnership with Wiley for publishing these three prestigious journals that are a vital component of our ever-expanding scientific portfolio," said Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer. "The Association is committed to accelerating the international effort to eliminate this devastating diseases, and these journals are an important forum for sharing the latest research about Alzheimer's and related dementias with the global scientific community."?
Alzheimer's & Dementia: Journal of the Alzheimer's Association aims to bridge knowledge gaps separating traditional fields of dementia research by covering the entire spectrum from basic science to clinical trials and social and behavioral investigations. The journal provides a forum for rapid communication of new findings and ideas; disseminating knowledge necessary for optimal translation of research findings into practical application and interventions; increasing knowledge in diverse disciplines to promote early detection, diagnosis and/or interventions; identifying promising new directions of research; and providing the scientific impetus for new initiatives.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages.
Alzheimer's & Dementia: Translational Research & Clinical Interventions seeks to advance and expedite clinical translational research in Alzheimer's disease and age-related cognitive impairment into improved care and treatment, and promote open-access communication across preclinical, clinical, and effectiveness research areas.
"Wiley has long admired the Alzheimer's Association and respected its organizational commitment to education, excellence and openness," said Shawn Morton, health sciences publishing director. "We know that Alzheimer's & Dementia is one of the top journals in the clinical neurology field with a rapidly growing impact factor and we look forward to working with the Alzheimer's Association and the scientific community to further expand the Journal family reach and relevance."
###
Additional Information
About The Alzheimer's Association
The Alzheimer's Association is the largest Alzheimer's voluntary health organization with a mission to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Wiley is proud to partner with the Alzheimer's Association to advance their vision of a world without Alzheimer's disease. Follow us on Twitter @alzassociation
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at http://www.wiley.com.
Alzheimer's Association Contact:
Jann Ingmire
+1 (312) 335-5704
jlingmire@alz.org
Wiley Media Contacts:
Tom Griffin (APAC): +617 38599 740
Penny Smith (UK): +44 1243 770448
Dawn Peters (US): +1 781-388-8408
newsroom@wiley.com
Follow us on Twitter @WileyNews